Clinical Trial Update: Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating a multi-antigen CMV-modified vaccinia Ankara vaccine in pediatric patients undergoing donor stem cell transplantation for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Multi-antigen CMV-modified Vaccinia Ankara vaccine (CMV-modified vaccinia Ankara vaccine)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Cytomegaloviral Infection, Hematopoietic Cell Transplant Recipient | Phase 1, Phase 2 | Status: RECRUITING